ENLV

1.05010.26%
DM

Dror Mevorach

Founder & Scientific Advisor

Prof. Dror Mevorach, M.D., is founder of Enlivex Therapeutics Ltd and has been its Scientific Advisor and its Consultant since March 01, 2024 and was Chief Scientific & Medical Officer since 2009 until March 01, 2024. Prof. Mevorach is a leading scientist on the removal of apoptotic cells and the Co-Chaired several Apoptotic Cell Recognition and Clearance at Gordon Research Conference and in international meetings. Prof. Mevorach is currently the Chairman of Medicine and the Director of the Rheumatology Research Centre of Hadassah-Hebrew University Hospital and School of Medicine in Jerusalem. Prof. Mevorach published more than many scientific papers and is a frequent lecturer at international conferences. Prof. Mevorach earned his M.D. (Cum Laude) from The Technion – Israel Institute of Technology in Haifa, Israel and was a fellow at the Hospital for Special Surgery and Cornell Medical School, NY.

Positions